Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

KURA holding history

Kura Oncology, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KURA overviewAll 13F holders of KURAFull Q2 2026 holdings

Shares (Q2 2026)
964,636
Value
$10.6M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KURA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026964,636$10.6M<0.1%−75,597−7.3%ReducedHolders
Q1 20261,040,233$8.46M<0.1%−19,792−1.9%ReducedHolders
Q4 20251,060,025$11.0M<0.1%+574,455+118.3%AddedHolders
Q3 2025485,570$4.30M<0.1%+373,287+332.5%AddedHolders
Q2 2025112,283$647.9K<0.1%−27,242−19.5%ReducedHolders
Q1 2025139,525$920.9K<0.1%−175,950−55.8%ReducedHolders
Q4 2024315,475$2.75M<0.1%+185,659+143.0%AddedHolders
Q3 2024129,816$2.54M<0.1%+38,039+41.4%AddedHolders
Q2 202491,777$1.89M<0.1%−135,044−59.5%ReducedHolders
Q1 2024226,821$4.84M<0.1%+23,864+11.8%AddedHolders
Q4 2023202,957$2.92M<0.1%+120,612+146.5%AddedHolders
Q3 202382,345$751.0K<0.1%+82,328+484,282.4%AddedHolders
Q2 202317$180<0.1%−214,123−100.0%ReducedHolders
Q1 2023214,140$2.62M<0.1%−796−0.4%ReducedHolders
Q4 2022214,936$2.67M<0.1%+181,705+546.8%AddedHolders
Q3 202233,231$454.0K<0.1%−28,017−45.7%ReducedHolders
Q2 202261,248$1.12M<0.1%−127,571−67.6%ReducedHolders
Q1 2022188,819$3.04M<0.1%+24,012+14.6%AddedHolders
Q4 2021164,807$2.31M<0.1%+153,363+1,340.1%AddedHolders
Q3 202111,444$214.0K<0.1%−2,159−15.9%ReducedHolders
Q2 202113,603$284.0K<0.1%−44,396−76.5%ReducedHolders
Q1 202157,999$1.64M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.